Brief: Finch Therapeutics Reports Q1 2023 Financial Results And Provides Business Updates
10/05/2023 13:48
May 10 (Reuters) - Finch Therapeutics Group Inc
FNCH.O :
* FINCH THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
* FINCH THERAPEUTICS GROUP INC - CASH AND CASH EQUIVALENTS
AS OF
MARCH 31, 2023 WERE $41.7 MILLION
* FINCH THERAPEUTICS GROUP - BELIEVES CASH, CASH EQUIVALENTS
ON
HAND AS OF MARCH 31 WILL BE SUFFICIENT TO FUND OPERATING
EXPENSES, CAPEX INTO 2025
Source text for Eikon: ID:nGNX8Y7CJW
Further company coverage: FNCH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp